Venditti, A., Piciocchi, A., Candoni, A., Arena, V., Palmieri, R., Fili, C., et al. (2024). Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial. BLOOD ADVANCES, 8(16), 4410-4413 [10.1182/bloodadvances.2024013182].
Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial
Cairoli R.;
2024
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Venditti-2024-Blood Adv-Vor.pdf
accesso aperto
Descrizione: CC BY-NC-ND 4.0 © 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0),
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
451.09 kB
Formato
Adobe PDF
|
451.09 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
